新規ヌクレオシド系抗ヘルペス剤A-5021と関連化合物の合成研究

抄録

A series of conformationally constrained nucleoside analogues with two hydroxymethyl groups mimicking the 3'- and 5'-hydroxyl groups of the 2'-deoxyribose were prepared and evaluated for their antiherpetic activity. Among those, 9- [[cis-1'-, 2'-bis (hydroxylmethyl) cycloprop-1'-yl] methy] guanine showed extremely potent antiviral activity against HSV-1. One of the enantiomers with (1'S), (2'R) -configuration (A-5021) was proved to be the active form. A-5021 was more active than acyclovir (ACV) against HSV-1, HSV-2, VZV, HCMV and showed superior activity over ACV in animal models. An efficient process for preparation of A-5021 including enantioselective hydrolysis of the intermediate is described. An oral prodrug AV-038 and anti-VZV drug AV-100 are also described.